# Fei Han

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/fei-han/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,684 |
| Field | Head and Neck Cancer Studies |
| h-index | 58 |
| i10-index | 178 |
| Last Known Institution | Jiangsu University |
| OpenAlex ID | https://openalex.org/A5090937408 |
| ORCID iD | 0000-0002-1598-9048 |
| Works | 413 |

## Researcher papers

- [Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma](https://scholariq.org/papers/gemcitabine-and-cisplatin-induction-chemotherapy-in-nasopharyngeal-carcinoma/)
- [SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart](https://scholariq.org/papers/sglt2-inhibition-with-empagliflozin-attenuates-myocardial-oxidative-stress-and/)
- [Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities](https://scholariq.org/papers/long-term-outcomes-of-intensity-modulated-radiotherapy-for-868-patients-with/)
- [The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma](https://scholariq.org/papers/the-chinese-society-of-clinical-oncology-csco-clinical-guidelines-for-the/)
- [CD155T/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer](https://scholariq.org/papers/cd155t-tigit-signaling-regulates-cd8-t-cell-metabolism-and-promotes-tumor/)
- [Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy](https://scholariq.org/papers/local-control-survival-and-late-toxicities-of-locally-advanced-nasopharyngeal/)
- [Long-Term Outcomes of Early-Stage Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy Alone](https://scholariq.org/papers/long-term-outcomes-of-early-stage-nasopharyngeal-carcinoma-patients-treated-with/)
- [MicroRNA‐21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice](https://scholariq.org/papers/microrna-21-protects-from-mesangial-cell-proliferation-induced-by-diabetic/)
- [Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy](https://scholariq.org/papers/long-term-treatment-outcome-of-recurrent-nasopharyngeal-carcinoma-treated-with/)
- [Phase III Study Comparing Standard Radiotherapy With or Without Weekly Oxaliplatin in Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma: Preliminary Results](https://scholariq.org/papers/phase-iii-study-comparing-standard-radiotherapy-with-or-without-weekly/)
- [Genomic Landscape and Tumor Mutational Burden Determination of Circulating Tumor DNA in Over 5,000 Chinese Patients with Lung Cancer](https://scholariq.org/papers/genomic-landscape-and-tumor-mutational-burden-determination-of-circulating-tumor/)

## Researcher topics

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Head and Neck Surgical Oncology](https://scholariq.org/topics/head-and-neck-surgical-oncology/)
- [Advanced MRI Techniques and Applications](https://scholariq.org/topics/advanced-mri-techniques-and-applications/)
- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

## Researcher university

- [Jiangsu University](https://scholariq.org/institutions/jiangsu-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.